Cargando…

Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?

Detalles Bibliográficos
Autores principales: Chapman, Thomas P., Revés, Joana, Torres, Joana, Satsangi, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437698/
https://www.ncbi.nlm.nih.gov/pubmed/34529994
http://dx.doi.org/10.1053/j.gastro.2021.09.019
_version_ 1783752209162305536
author Chapman, Thomas P.
Revés, Joana
Torres, Joana
Satsangi, Jack
author_facet Chapman, Thomas P.
Revés, Joana
Torres, Joana
Satsangi, Jack
author_sort Chapman, Thomas P.
collection PubMed
description
format Online
Article
Text
id pubmed-8437698
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-84376982021-09-14 Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY? Chapman, Thomas P. Revés, Joana Torres, Joana Satsangi, Jack Gastroenterology Selected Summaries by the AGA Institute 2021-12 2021-09-14 /pmc/articles/PMC8437698/ /pubmed/34529994 http://dx.doi.org/10.1053/j.gastro.2021.09.019 Text en © 2021 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Selected Summaries
Chapman, Thomas P.
Revés, Joana
Torres, Joana
Satsangi, Jack
Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
title Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
title_full Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
title_fullStr Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
title_full_unstemmed Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
title_short Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?
title_sort anti–sars-cov-2 antibody responses in patients with ibd treated with biologics: are we finding clarity?
topic Selected Summaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437698/
https://www.ncbi.nlm.nih.gov/pubmed/34529994
http://dx.doi.org/10.1053/j.gastro.2021.09.019
work_keys_str_mv AT chapmanthomasp antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity
AT revesjoana antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity
AT torresjoana antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity
AT satsangijack antisarscov2antibodyresponsesinpatientswithibdtreatedwithbiologicsarewefindingclarity